Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells
Eleonora Fonte,
Maria Giovanna Vilia,
Daniele Reverberi,
Ilenia Sana,
Lydia Scarfò,
Pamela Ranghetti,
Ugo Orfanelli,
Simone Cenci,
Giovanna Cutrona,
Paolo Ghia,
Marta Muzio
Affiliations
Eleonora Fonte
Cell Signaling Unit, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milano, Italy
Maria Giovanna Vilia
Cell Signaling Unit, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milano, Italy
Daniele Reverberi
UOC Patologia Molecolare, IRCCS AOU S. Martino-IST, Genova, Italy
Ilenia Sana
Cell Signaling Unit, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milano, Italy
Lydia Scarfò
B-Cell Neoplasia Unit and Strategic Research Program on CLL, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milano, Italy;Università Vita-Salute San Raffaele, Milano, Italy
Pamela Ranghetti
B-Cell Neoplasia Unit and Strategic Research Program on CLL, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milano, Italy
Ugo Orfanelli
Age Related Diseases Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Hospital, Milano, Italy
Simone Cenci
Age Related Diseases Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Hospital, Milano, Italy
Giovanna Cutrona
UOC Patologia Molecolare, IRCCS AOU S. Martino-IST, Genova, Italy
Paolo Ghia
B-Cell Neoplasia Unit and Strategic Research Program on CLL, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milano, Italy;Università Vita-Salute San Raffaele, Milano, Italy
Marta Muzio
Cell Signaling Unit, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milano, Italy
Chronic lymphocytic leukemia cells strongly depend on external stimuli for their survival. Both antigen receptor and co-stimulatory receptors, including Toll-like receptors, can modulate viability and proliferation of leukemic cells. Toll-like receptor ligands, and particularly the TLR9 ligand CpG, mediate heterogeneous responses in patients’ samples reflecting the clinical course of the subjects. However, the molecular framework of the key signaling events underlying such heterogeneity is undefined. We focused our studies on a subset of chronic lymphocytic leukemia cases characterized by expression of CD38 and unmutated immunoglobulin genes, who respond to CpG with enhanced metabolic cell activity. We report that, while CpG induces NFKBIZ mRNA in all the samples analyzed, it induces the IκBζ protein in a selected group of cases, through an unanticipated post-transcriptional mechanism. Interestingly, IκBζ plays a causal role in sustaining CpG-induced cell viability and chemoresistance, and CpG stimulation can unleash immunoglobulin secretion by IκBζ-positive malignant cells. These results identify and characterize IκBζ as a marker and effector molecule of distinct key pathways in chronic lymphocytic leukemia.